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Background
• Cancer is a disease of uncontrolled cell proliferation. DNA replication
occurs more frequently due to loss of cell cycle control mechanisms,
leading to tumor propagation.
• Berberine is a planar, aromatic compound under investigation as a
treatment for certain cancers. Berberine may induce cancer cell apoptosis
by intercalating into the bases of the cell’s DNA, thus inhibiting replication
and suppressing tumor growth.

Figure 1: Structure of Berberine.
Number labels represent peak positions
on berberine’s 1HNMR spectrum.

Methods
• Samples were prepared using serial dilutions of caffeine and berberine in
D2O with 4,4-Dimethyl-4-silapentane-1-sulfonic acid (DSS) reference
standard, providing a range of concentrations for each sample set.
• Caffeine samples and Berberine samples were each tested at 25̊ C and
35 ̊C and compared to mixtures of the two compounds together at the
same temperatures.
• 1HNMR experiments were run on a Varian Unity INOVA® 500MHz NMR.
• An NMR stack of chemical shift behavior was prepared for each sample
using MestreNova analysis software. Peak chemical shifts were analyzed
for potential interaction using Ka calculations on MestreNova and
Microsoft Excel.

• Caffeine is also a planar molecule which may interfere with the
effectiveness of anti-cancer intercalating agents such as berberine by
directly binding with the drug and preventing it from targeting the DNA of
cancer cells.
Figure 2: Structure of Caffeine.
Number labels represent peak positions
on caffeine’s 1HNMR spectrum.

• NMR Spectroscopy was used to analyze the chemical shifts of aqueous
samples of caffeine and berberine molecules individually and in mixture to
determine association constants (Ka) and derive points of interaction
between the two molecules. Understanding these interactions will
contribute to understanding effectiveness of Berberine as an anticancer
drug and caffeine’s role in inhibiting the effects of berberine in fighting
cancer.

Figure 4: Methods of Chemical Analysis. Berberine 5mM sample set in NMR capillary tubes,
Berberine 5mM original solution, and 1HNMR spectrum of Berberine 5mM Sample 1 at 25 degrees
(top left); Bethany Kregger placing sample in Varian Unity INOVA® 500MHz NMR (bottom left); Data
Scatterplot of Berberine 5mM Peak 5 Chemical Shift using experimental values at 25 degrees and
trendline values to determine Ka (top right); Graph of Change in Ka value from Berberine 5mM
Standard sample set at 25 degrees to other relevant sample sets, where increase indicates that Ka is
higher in Berberine 5mM sample set and decrease indicates that Ka is higher in compared sample set
(bottom right).

Key Findings

Figure 3: NMR Stack of Chemical Shift Behavior using MestreNova Analysis Software. Samples
range from high concentration (top of each stack) to low concentration (bottom of each stack) for
each sample set. Peak 3 of caffeine in Caffeine Standard sample set at 25 degrees (top left); Peak 3
of caffeine in Berberine/Caffeine Mixture sample set at 25 degrees (bottom left); Peak 5 of berberine
in Berberine 5mM Standard sample set at 25 degrees (top right); Peak 5 of berberine in
Caffeine/Berberine Mixture sample set at 25 degrees (bottom right).
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• Berberine’s distinctly higher peak 3 Ka in standard than in mixture indicates that
peak 3 may be more involved in self-stacking than in interacting with caffeine.
• Berberine’s increased Ka values at peaks 1, 6, and 7 in mixture with caffeine
indicate that they may be involved in stacking with caffeine.
• In higher temperatures, there is a trend toward increase in Ka values of
berberine peaks, indicating that berberine may be more likely to self-associate
at body temperature than to interact with caffeine.
• In higher concentrations, berberine peaks tends to increase in Ka value,
indicating that berberine is more likely to self-associate than to repel like
molecules.
• At lower temperatures, increased Ka values indicate that berberine peak 1 as
well as peaks 5, 6, 7, and 11 may be involved in stacking with caffeine, while at
higher temperatures berberine peaks 1, 6, 7, 8, and 10 all show the opposite
trend and instead peaks 3, 5, and especially 9 may become more involved in
stacking behavior, whether with caffeine or in self-stacking.
• Overall, it might be inferred that at lower temperatures, multiple berberine peaks
(1, 5, 6, 7, 8, and 11) may play a role in associating with all caffeine peaks especially caffeine’s peak 4 – and in self-association. However, as temperatures
increase to conditions similar to body temperature, berberine may dissociate
from caffeine and increase in self-association at peaks 3, 5, and 9 while caffeine
may increase in self-association at peak 4.
• Further studies may benefit from measurements using different reference
standards for comparison, as there was some indication that the molecules
being studied may have had some level of interaction with the DSS reference
standard.

